Yuhan’s lung cancer drug gets OK in Europe

Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca

Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca

Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...

Yuhan’s lung cancer drug clears FDA hurdle for global debut

Yuhan’s lung cancer drug clears FDA hurdle for global debut

A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...

Lunit participates in US gov't Cancer Moonshot

Lunit participates in US gov't Cancer Moonshot

South Korea's medical AI company Lunit announced on Friday it will participate in the US President Joe Biden's cancer-conquering project Cancer Moon...

S.Korea’s Coreline Soft teams up with HCK of Switzerland

S.Korea’s Coreline Soft teams up with HCK of Switzerland

South Korea's Coreline Soft, a maker of artificial intelligence (AI)-based imaging diagnostic materials, on Wednesday said it will sell its chest di...

S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug

S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug

South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...

Clinomics releases equipment that quickly finds lung cancer mutations

Clinomics releases equipment that quickly finds lung cancer mutations

Clinomics, a South Korean biotech company specializing in liquid biopsies, on Thursday said it developed equipment that can detect four types of l...

Bridge Biotherapeutics, Pinotbio develop lung cancer treatment

Bridge Biotherapeutics, Pinotbio develop lung cancer treatment

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

Celltrion wins sales approval for biosimilar Vegzelma in Japan

Celltrion wins sales approval for biosimilar Vegzelma in Japan

Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...

Korea Hanmi to launch blockbuster hypertension drug in China

Korea Hanmi to launch blockbuster hypertension drug in China

South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared